South Korea · Healthcare · KRW (Millions) · Annual
Key financials
KRW|Millions
ROE
20.44%
2025 (actual)
ROA
18.39%
2025 (actual)
Gross Margin
44.1%
2025 (actual)
Net Margin
23.19%
2025 (actual)
Total Assets
₩217,077.49M
2025 (actual)
Net Income
₩38,074.88M
2025 (actual)
Valuation
₩393,240.28M
2026 (forecast)
Stock Price
₩24,525
Historical & projected performance
KRW|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-6.9 pt
Company
ROA
-6.2 pt
Company
Gross Margin
-8.7 pt
Company
Sector average
Net Margin
-5.2 pt
Company
Total Assets
+187.1%
Company
Sector average
Net Income
+87.6%
Company
Sector average (own scale)
Valuation
+7.1%
Company
Sector average
Stock Price
+7.1%
Company
Sector average
Amounts in KRW (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for T&L Co., Ltd.? It covers the balance sheet, income statement, cash flow and Equlion model projections.